Embark Technology Inc (EMBK) Fundamental Analysis & Valuation

NASDAQ:EMBKUS29079J2024

Current stock price

2.88 USD
+0.01 (+0.35%)
At close:
2.87 USD
-0.01 (-0.35%)
After Hours:

This EMBK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EMBK Profitability Analysis

1.1 Basic Checks

  • EMBK had negative earnings in the past year.
  • EMBK had a negative operating cash flow in the past year.
EMBK Yearly Net Income VS EBIT VS OCF VS FCFEMBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

  • The profitability ratios for EMBK are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMBK Yearly ROA, ROE, ROICEMBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -10 -20 -30 -40 -50

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EMBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMBK Yearly Profit, Operating, Gross MarginsEMBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

4

2. EMBK Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EMBK has been increased compared to 1 year ago.
  • EMBK has a worse debt/assets ratio than last year.
EMBK Yearly Shares OutstandingEMBK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
EMBK Yearly Total Debt VS Total AssetsEMBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -3.84, we must say that EMBK is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of EMBK (-3.84) is worse than 85.71% of its industry peers.
  • EMBK has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • EMBK has a Debt to Equity ratio (0.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.84
ROIC/WACCN/A
WACCN/A
EMBK Yearly LT Debt VS Equity VS FCFEMBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

  • EMBK has a Current Ratio of 11.38. This indicates that EMBK is financially healthy and has no problem in meeting its short term obligations.
  • EMBK's Current ratio of 11.38 is amongst the best of the industry. EMBK outperforms 96.43% of its industry peers.
  • A Quick Ratio of 11.38 indicates that EMBK has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 11.38, EMBK belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.38
Quick Ratio 11.38
EMBK Yearly Current Assets VS Current LiabilitesEMBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M 250M

0

3. EMBK Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.60% over the past year.
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, EMBK will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.35% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMBK Yearly Revenue VS EstimatesEMBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
EMBK Yearly EPS VS EstimatesEMBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -2 -4 -6

0

4. EMBK Valuation Analysis

4.1 Price/Earnings Ratio

  • EMBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMBK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMBK Price Earnings VS Forward Price EarningsEMBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMBK Per share dataEMBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

  • A cheap valuation may be justified as EMBK's earnings are expected to decrease with -27.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.35%
EPS Next 3YN/A

0

5. EMBK Dividend Analysis

5.1 Amount

  • No dividends for EMBK!.
Industry RankSector Rank
Dividend Yield N/A

EMBK Fundamentals: All Metrics, Ratios and Statistics

Embark Technology Inc

NASDAQ:EMBK (8/1/2023, 8:00:02 PM)

After market: 2.87 -0.01 (-0.35%)

2.88

+0.01 (+0.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-10
Earnings (Next)11-06
Inst Owners1.62%
Inst Owner Change0%
Ins Owners2.19%
Ins Owner Change0%
Market Cap70.20M
Revenue(TTM)N/A
Net Income(TTM)-147.78M
Analysts43.33
Price Target3.06 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.37%
Min EPS beat(2)18.37%
Max EPS beat(2)18.37%
EPS beat(4)3
Avg EPS beat(4)30.66%
Min EPS beat(4)5.24%
Max EPS beat(4)68.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-4.44
EYN/A
EPS(NY)-7.2
Fwd EYN/A
FCF(TTM)-4.9
FCFYN/A
OCF(TTM)-4.49
OCFYN/A
SpS0
BVpS5.16
TBVpS5.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 368%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.38
Quick Ratio 11.38
Altman-Z -3.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)349.02%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.75%
EBIT Next 3Y-10.05%
EBIT Next 5Y-11.83%
FCF growth 1Y-57.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.07%
OCF growth 3YN/A
OCF growth 5YN/A

Embark Technology Inc / EMBK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Embark Technology Inc?

ChartMill assigns a fundamental rating of 1 / 10 to EMBK.


Can you provide the valuation status for Embark Technology Inc?

ChartMill assigns a valuation rating of 0 / 10 to Embark Technology Inc (EMBK). This can be considered as Overvalued.


Can you provide the profitability details for Embark Technology Inc?

Embark Technology Inc (EMBK) has a profitability rating of 0 / 10.


Can you provide the financial health for EMBK stock?

The financial health rating of Embark Technology Inc (EMBK) is 4 / 10.


What is the expected EPS growth for Embark Technology Inc (EMBK) stock?

The Earnings per Share (EPS) of Embark Technology Inc (EMBK) is expected to decline by -69.54% in the next year.